{"id":"W2991540591","doi":"10.1016/j.jaci.2019.11.025","title":"Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial","year":2019,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":357,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"AbbVie","keywords":"Medicine; Placebo; Randomized controlled trial; Atopic dermatitis; Eczema Area and Severity Index; Adverse effect; Clinical endpoint; Internal medicine; Surgery; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009075955,0.0001960163,0.002171915,0.000162476,0.00003812038,0.00001684906,0.0001415848,0.0003461642,0.0002812372],"category_scores_gemma":[0.001917811,0.0001253048,0.0003469753,0.00008498949,0.0002268407,0.0001264055,0.00004811853,0.0007007576,0.00004693927],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002488432,"about_ca_system_score_gemma":0.0002722181,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005379156,"about_ca_topic_score_gemma":0.000162962,"domain_scores_codex":[0.996527,0.0008635442,0.001906968,0.0002678644,0.0001794268,0.0002552201],"domain_scores_gemma":[0.9953529,0.003357978,0.0006795113,0.0002349065,0.0001875278,0.0001871723],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9913045,0.0008131216,0.001631614,0.00001031147,0.003085516,0.0005379903,0.0003093273,0.00003192971,0.000002219243,0.00008372018,0.001010708,0.00117901],"study_design_scores_gemma":[0.9733443,0.002691302,0.02014236,0.0006059738,0.0002679254,0.0005825742,0.0003381065,0.0002116328,0.000009384571,0.0007766847,0.0008882518,0.0001414539],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895116,0.001887515,0.00006793462,0.004538927,0.0006561404,0.001215146,0.000008695404,0.00001068513,0.002103341],"genre_scores_gemma":[0.9946197,0.00204138,0.0003712108,0.002049237,0.0001933503,0.00002853869,0.00001469891,0.00001266165,0.0006692036],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01851075,"threshold_uncertainty_score":0.5109781,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01379008931329156,"score_gpt":0.2865810797549208,"score_spread":0.2727909904416292,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}